Early intervention could halve angina rate for people at moderate risk of heart attack

August 31, 2002

Authors of a UK study published in this week's issue of THE LANCET suggest that angina could be halved if an interventional approach (such as balloon angioplasty or coronary artery bypass surgery) is used to treat people soon after they have been identified as being at moderate risk of heart attack.

Considerable debate surrounds the treatment of patients who show signs of being at risk of heart attack. Current guidelines suggest that, for such patients with unstable coronary syndromes who are at moderate risk of death from coronary-artery disease, either an interventional strategy (angiography followed by revascularisation [restoration of coronary artery bloodflow by angioplasty or coronary artery bypass surgery]) or a conservative 'wait and see' strategy is appropriate.

Keith Fox, lead investigator of the British Heart Foundation Randomised Intervention Trial of unstable Angina (RITA) and colleagues did a randomised multicentre trial of 1810 patients at moderate risk of heart attack. Patients were assigned to either an intervention or conservative treatment group. Patients assigned to intervention were given angiography and (if necessary) revascularisation. Conservative treatment was a 'wait and see' strategy with subsequent intervention if needed. The anti-clotting drug enoxaparin was used in both treatment groups.

At 4 months, 9.6% of patients in the intervention group had died, had a heart attack, or had angina, compared with 14.5% of patients in the conservative group-mainly due to a halving of angina in the intervention group. Rates of death and heart attack were similar between the two groups at one year follow-up. Around a quarter of patients given conservative treatment subsequently required surgery for coronary revascularisation within one year.

Keith Fox comments: "Our study has shown that, among patients with unstable coronary syndromes, the combined endpoint of death, non-fatal heart attack, or severe angina is significantly reduced in patients assigned intervention, and that the main effect was on severe angina. Conclusive evidence for the effect on prognosis (death or heart attack) will require completion of the planned 5 year follow-up. As in previous studies, the hazards of intervention seem to be more than counterbalanced by the subsequent reduction in risk of heart attack."

In an accompanying Commentary (p 738), Lars Wallentin from University Hospital Uppsala, Sweden, concludes: "Based on the [previously published] randomised trials, RITA 3, observational data, and clinical experience, an early invasive compared with a non-invasive strategy improves survival without recurrence of myocardial infarction and re-admission or urgent revascularisation for severe angina. The effects are greatest in intermediate-risk and high-risk patients based on non-invasive risk indicators on admission. In women the effects on prognosis are uncertain and might be unfavourable, necessitating a more cautious approach to invasive procedures. These conclusions accord with the guidelines from the ESC [European Society of Cardiology] and ACC/American Heart Association that will be published in 2002. Further studies are needed to improve methods to reduce the risks associated with invasive procedures, to explore new treatment alternatives in women, and to prevent recurrences of instability in the longer term."
-end-
Contact:
Professor Keith Fox, c/o Ronald Kerr,
University of Edinburgh Press Office;
T) 44-131-650-9547;
E) Ronald.kerr@ed.ac.uk;
Professor Keith Fox (mobile)
44-778-615-8881

Professor Lars Wallentin,
Uppsala Clinical Research Centre,
University Hospital, Uppsala,
S-751 85 Uppsala, Sweden;
T) 46-18-66-43-93;
F) 46-18-50-66-38;
E) lars.wallentin@ucr.uu.se

Lancet

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.